top of page
Our Blog
See below for an opinion on current matters around the world.
Search


WFH ... WTF ... ????: Working-from-home, employer reaction and pandemic-inspired industrial changes
Brendan Shaw "If after 15 months, you have only a 'suspicion' about what your people are up to and find it 'hard to know' who are your...
Brendan Shaw
Aug 7, 20248 min read
91 views
0 comments


Time to Build More Windmills: Reflections from the ChinaBio Innovation & Investment Conference 2023
Brendan Shaw Article published in PharmaBoardroom 19 October 2023 that can be found here: https://pharmaboardroom.com/articles/time-to-bu...
Brendan Shaw
Oct 21, 20231 min read
8 views
0 comments


Arm Doors and Cross-Check: What the Health Sector Can Learn from the Post-COVID Airline Industry
Brendan Shaw Article "Arm Doors and Cross-Check: What the Health Sector Can Learn from the Post-COVID Airline Industry Debacle",...
Brendan Shaw
Aug 30, 20221 min read
24 views
0 comments


Workers of the world resign!: What if post-pandemic staff refuse to return to the office?
Brendan Shaw "Natural ragione è di ciascuno che ci nasce, la sua vita, quanto può, aiutare e conservare e difendere (Every person born...
Brendan Shaw
Aug 19, 20218 min read
163 views
0 comments


Opportunities for the Life Science Industry in Australia post-COVID
Brendan Shaw Article published 24 May 2021 on opportunities for Australia's life science sector in a post-COVID world can be found here....
Brendan Shaw
May 24, 20211 min read
10 views
0 comments


The new frontier: emerging regulatory issues in cell and gene therapies
Sunayana Shah and Brendan Shaw Cell and gene therapies promise great clinical value for patients, society, and healthcare systems. They...
Brendan Shaw
Oct 1, 20208 min read
284 views
0 comments


Creeping Through the Backdoor: Disruption in Medicine and Health
Brendan Shaw and Orin Chisholm Article published in the journal Frontiers in Pharmacology on 10 June 2020 on whether health systems can...
Brendan Shaw
Jun 11, 20201 min read
18 views
0 comments


When profit isn’t everything: 46,000 years of cultural history vs the iron ore spot price
Brendan Shaw “Our people are deeply troubled and saddened by the destruction of these rock shelters and are grieving the loss of...
Brendan Shaw
Jun 3, 20205 min read
214 views
0 comments


Space X and NASA: lessons on public-private R&D for the health debate
Brendan Shaw On 30 May, the Space X Dragon rocket blasted off from the Kennedy Space Centre in Florida and delivered two NASA astronauts...
Brendan Shaw
May 31, 20203 min read
71 views
0 comments


New industrial policy for biopharmaceutical and devices industry needs careful thought
Article published in BioPharmaDispatch on 17 April 2020 about the debate in Australia on expanding national manufacturing capacity in...
Brendan Shaw
Apr 17, 20201 min read
12 views
0 comments


HTA 2.0: time for a reboot
A few days spent at the Health Technology Assessment International (HTAi) 2019 conference in Cologne this week gave a sense of how the...
Brendan Shaw
Jun 20, 20195 min read
202 views
0 comments


Alzheimer's failure a lesson in why pharma companies are vital
News that a joint research project by pharmaceutical companies Biogen and Eisai to develop a new drug to treat Alzheimer's Disease has...
Brendan Shaw
Apr 18, 20192 min read
57 views
0 comments


Crouching dragons and hidden tigers: the emergence of China’s life sciences sector
"Our greatest glory is not in never falling, but in rising every time we fall" - Confucius China’s life sciences industry is still...
Brendan Shaw
Nov 16, 20185 min read
111 views
0 comments


My failure as a Rockstar: lessons from technological change in the music industry
In 2001, a little-known rock band started and ended its career in Melbourne, Australia. The band, Boxer, a folk-rock/pop band with a...
Brendan Shaw
Oct 20, 20184 min read
87 views
0 comments


Doing it for Jane: eradicating tuberculosis
Sometimes in discussions of global health we get lost in the numbers. It's something I am often guilty of myself. Individual stories of...
Brendan Shaw
Sep 24, 20184 min read
40 views
0 comments


To price or not to price, that is the question
What price to put on a medicine is one of the big issues in global health right now. While there are times when the debate around drug...
Brendan Shaw
Jun 28, 20185 min read
45 views
0 comments


Don't forget the future: Alzheimer's disease and the economics of drug development
The story of the pharmaceutical industry’s efforts to find a treatment for Alzheimer’s disease is a classic example of why a commercially...
Brendan Shaw
May 31, 20185 min read
111 views
0 comments


Disruptive innovation in the health sector – are we ready for it?
“Breaking an old business model is always going to require leaders to follow their instinct. There will always be persuasive reasons not...
Brendan Shaw
Mar 22, 20186 min read
221 views
0 comments


Innovation policy is the new black
When I was a young economist starting my career in government many years ago I wasn't part of the 'in' crowd. I believed in a clever,...
Brendan Shaw
Mar 12, 20183 min read
44 views
0 comments


Memo to life sciences executives: Happy New Year, take a deep breath and think big
As life sciences companies head into their annual strategic kick-off meetings for the year, spare a thought for their CEOs and senior...
Brendan Shaw
Jan 26, 20186 min read
63 views
0 comments
bottom of page